Polymorphisms in CCR5 chemokine receptor gene in Japan

International Journal of Immunogenetics

Volumn 34, Issue 5, 2007, Pages 325-335

  Liu, H ^a,b   Nakayama, E E ^a   Theodorou, I ^c   Nagai, Y ^d   Likanonsakul, S ^e   Wasi, C ^f   Debre, P ^c   Iwamoto, A ^g   Shioda, T ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d RIKEN YOKOHAMA INSTITUTE   (Japan)

^e Bamrasnaradura Infectious Disease Institute   (Thailand)

^f MAHIDOL UNIVERSITY   (Thailand)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE COURSE; GENE AMPLIFICATION; GENE DELETION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; JAPAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THAILAND;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; HAPLOTYPES; HIV-1; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RECEPTORS, CCR5;

HUMAN IMMUNODEFICIENCY VIRUS 1; THAIS;

EID: 34548533866     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00694.x     Document Type: Article

References (42)

1. Alkhatib, G., Combadiere, C., Broder, C.C. et al 1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 272, 1955.
2. Bamshad, M.J., Mummidi, S., Gonzalez, E. et al 2002) A strong signature of balancing selection in the 5′-cis-regulatory region of CCR5. Proceedings of the National Academy of Sciences of the USA, 99, 10539.
3. Barcellos, L.F., Schito, A.M., Rimmler, J.B. et al 2000) CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics, 51, 281.
4. Bream, J.H., Young, H.A., Rice, N. et al 1999) CCR5 promoter alleles and specific DNA binding factors. Science, 284, 223.
5. Carrington, M., Dean, M., Martin, M.P. O'Brien, S.J. (1999) Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. Human Molecular Genetics, 8, 1939.
6. Clark, A.G. (1990) Inference of haplotypes from PCR-amplified samples of diploid populations. Molecular Biology and Evolution, 7, 111.
7. Dean, M., Carrington, M., Winkler, C. et al 1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science, 273, 1856.
8. Deng, H., Liu, R., Ellmeier, W. et al 1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature, 381, 661.
9. + cells is mediated by the chemokine receptor CC- CKR-5. Nature, 381, 667.
10. Feng, Y., Broder, C.C., Kennedy, P.E. Berger, E.A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science, 272, 872.
11. Fischereder, M., Luckow, B., Hocher, B. et al 2001) CC chemokine receptor 5 and renal-transplant survival. Lancet, 357, 1758.
12. Garred, P., Madsen, H.O., Petersen, J. et al 1998) CC chemokine receptor 5 polymorphism in rheumatoid arthritis. Journal of Rheumatology, 25, 1462.
13. Gomez-Reino, J.J., Pablos, J.L., Carreira, P.E. et al 1999) Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis and Rheumatism, 42, 989.
14. Gonzalez, P., Alvarez, R., Batalla, A. et al 2001) Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes and Immunity, 2, 191.
15. Guignard, F., Combadiere, C., Tiffany, H.L. Murphy, P.M. (1998) Gene organization and promoter function for CC chemokine receptor 5 (CCR5). Journal of Immunology, 160, 985.
16. Hall, I.P., Wheatley, A., Christie, G. et al 1999) Association of CCR5 delta32 with reduced risk of asthma. Lancet, 354, 1264.
17. Huang, Y., Paxton, W.A., Wolinsky, S.M. et al 1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine, 2, 1240.
18. Kantor, R., Bakhanashvili, M. Achiron, A. (2003) A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology, 61, 238.
19. Kostrikis, L.G., Huang, Y., Moore, J.P. et al 1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Medicine, 4, 350.
20. Liu, H., Chao, D., Nakayama, E.E. et al 1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proceedings of the National Academy of Sciences of the USA, 96, 4581.
21. Liu, R., Paxton, W.A., Choe, S. et al 1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86, 367.
22. Magierowska, M., Theodorou, I., Debre, P. et al 1999) Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood, 93, 936.
23. Martin, M.P., Dean, M., Smith, M.W. et al 1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science, 282, 1907.
24. Martinson, J.J., Chapman, N.H., Rees, D.C., Liu, Y.T. Clegg, J.B. (1997) Global distribution of the CCR5 gene 32-basepair deletion. Nature Genetics, 16, 100.
25. McDermott, D.H., Zimmerman, P.A., Guignard, F. et al 1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet, 352, 866.
26. Meyer, L., Magierowska, M., Hubert, J.B. et al 1997) Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS, 11, F73.
27. Moriuchi, H., Moriuchi, M. Fauci, A.S. (1997) Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. Journal of Immunology, 159, 5441.
28. Mummidi, S., Ahuja, S.S., Gonzalez, E. et al 1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Medicine, 4, 786.
29. Mummidi, S., Ahuja, S.S., McDaniel, B.L. Ahuja, S.K. (1997) The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. Journal of Biological Chemistry, 272, 30662.
30. Mummidi, S., Bamshad, M., Ahuja, S.S. et al 2000) Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. Journal of Biological Chemistry, 275, 18946.
31. Nakayama, E.E., Tanaka, Y., Nagai, Y., Iwamoto, A. Shioda, T. (2004) A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS, 18, 729.
32. Newton, C.R., Graham, A., Heptinstall, L.E. et al 1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Research, 17, 2503.
33. Quillent, C., Oberlin, E., Braun, J. et al 1998) HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet, 351, 14.
34. Samson, M., Libert, F., Doranz, B.J. et al 1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722.
35. Shioda, T., Nakayama, E.E., Tanaka, Y. et al 2001) Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. Journal of Virology, 75, 3462.
36. Shioda, T., Oka, S., Ida, S. et al 1994) A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. Journal of Virology, 68, 7689.
37. Smith, M.W., Dean, M., Carrington, M. et al 1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science, 277, 959.
38. Spagnolo, P., Renzoni, E.A., Wells, A.U. et al 2005) C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. American Journal of Respiratory and Critical Care Medicine, 172, 721.
39. Valdes, A.M., Wolfe, M.L., O'Brien, E.J. et al 2002) Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1924.
40. Wu, L., Paxton, W.A., Kassam, N. et al 1997) CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. Journal of Experimental Medicine, 185, 1681.
41. Zheng, B.J., Zhao, X.Y., Zhu, N.S. et al 2002) Polymorphisms of CCR5 gene in a southern Chinese population and their effects on disease progression in HIV infections. AIDS, 16, 2480.
42. Zhu, T., Mo, H., Wang, N. et al 1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science, 261, 1179.